Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, PerformanceBridge Focal Point Version A.01, IntelliVue patient monitors MX100, MX400-MX850, and MP2-MP90 Versions N and prior, IntelliVue X3 and X2 Versions N and prior. The software does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is then used as a webpage and served to other users. Successful exploitation could lead to unauthorized access to patient data via a read-only web application.
CWE-79 - Cross Site Scripting
Cross-Site Scripting, commonly referred to as XSS, is the most dominant class of vulnerabilities. It allows an attacker to inject malicious code into a pregnable web application and victimize its users. The exploitation of such a weakness can cause severe issues such as account takeover, and sensitive data exfiltration. Because of the prevalence of XSS vulnerabilities and their high rate of exploitation, it has remained in the OWASP top 10 vulnerabilities for years.